Docetaxel with or without Ramucirumab after Platinum-Based Chemotherapy and Checkpoint Inhibitors in Advanced Urothelial Carcinoma: A Pre-Specified Subgroup Analysis from the Phase 3 RANGE Trial

  1. Drakaki, A.
  2. Kirby, C.J.
  3. Van Der Heijden, M.S.
  4. Petrylak, D.P.
  5. Powles, T.
  6. Chi, K.N.
  7. Fléchon, A.
  8. Necchi, A.
  9. Géczi, L.
  10. Lee, J.-L.
  11. Gakis, G.
  12. Bracarda, S.
  13. Chowdhury, S.
  14. Lin, C.-C.
  15. Keizman, D.
  16. Vaishampayan, U.N.
  17. Zimmermann, A.H.
  18. Bell-Mcguinn, K.
  19. Castellano, D.
Aldizkaria:
Bladder Cancer

ISSN: 2352-3735,  2352-3727

Argitalpen urtea: 2020

Alea: 6

Zenbakia: 1

Orrialdeak: 43-52

Mota: Artikulua

DOI: 10.3233/BLC-190252 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus